Articles tagged with Cancer Treatments
A study of 200 patients with head and neck cancer found that those with lower quality of life one year after treatment were more likely to die. The researchers discovered a correlation between steady-state QOL and long-term survival, suggesting that adjusting to the diagnosis and treatment may be crucial for better outcomes.
A two-year study of patients with early, aggressive RA demonstrates the superiority of anti-TNF plus DMARD therapy over either treatment alone. Nearly half of participants in the combined therapy group achieved major clinical remission after 2 years.
A four-month study found that art therapy sessions improved eight out of nine symptoms in cancer patients, with significant reductions in pain, tiredness, and anxiety. Patients reported feeling energized and benefited from the creative process as a form of expression.
Researchers found that a modest decrease in Mdm2 protein expression prevents tumor formation and does not lead to premature aging. Inhibitors of Mdm2 may delay cancer in young individuals without detrimental side effects.
A study by Dana-Farber Cancer Institute found that black lung cancer patients are less likely to undergo surgery, despite equal access to care. The researchers attributed this disparity to a complex 'communications problem' underlying the interaction between doctors and patients.
Researchers at Children's Hospital of Philadelphia found that parents of children with cancer often suffer from post-traumatic stress symptoms, including intrusive thoughts, avoidance behaviors, and heightened arousal. The studies suggest that these symptoms can be just as severe as those experienced by patients themselves.
A new study reveals that palliative care programs are increasingly available in US hospitals, particularly in larger institutions and those affiliated with not-for-profit organizations. The growing demand for quality of life and relief from suffering is driving the expansion of these programs.
A study of lung cancer patients found that those who did not participate in clinical trials were more likely to be African American, female, or over 70. The researchers suggest targeting specific patient subgroups to improve representation in clinical trials.
The Mayo Clinic Cancer Center has reported significant advancements in quality of life assessments for cancer patients. The researchers tackled philosophical and statistical issues to develop practical methods for capturing QOL data. They emphasized the importance of including patient perspectives to provide personalized care.
A new initiative launched by UICC's World Cancer Campaign will provide funding for 14 projects aimed at improving childhood cancer care in the developing world. The initiatives focus on early diagnosis, access to care, and support for children with cancer and their families.
Patients who quit smoking around cancer diagnosis have improved disease outcomes, better QOL, and prolonged survival compared to continuing smokers. Targeted interventions combining behavioral therapy and pharmacotherapy show promise in addressing individual barriers to cessation.
A systematic review of randomized controlled trials and meta-analysis found that melatonin reduced the risk of death at one year by 34%. Melatonin was also shown to have a beneficial effect on sleep patterns in patients. The researchers urge caution in interpreting the clinical usefulness of large doses of melatonin.
Hospital noise levels have grown steadily over the past five decades, exceeding World Health Organization guidelines, with human speech frequency range contributing to communication difficulties. Researchers at Johns Hopkins University found modest reductions by introducing hands-free personal communicators in patient areas.
A study of 24 patients found that MRI with an endorectal coil at 1.5T outperforms conventional body coils in staging prostate cancer. The results suggest a need for advances in coil technology to improve imaging at higher field strengths.
Researchers at Ohio State University discover cancer wasting is caused by loss of muscle protein dystrophin and damage to the dystrophin glycoprotein complex. This finding may lead to new ways to diagnose and treat the condition.
Researchers link muscular dystrophy and cancer-associated muscle wasting to dysfunctional dystrophin glycoprotein complex. Cachectic patients with gastrointestinal cancers show dramatic reductions in dystrophin levels, highlighting the shared mechanism of DGC dysfunction as a critical characteristic.
The study found that patients with rapid increases in PSA levels (PSAV) or quick doubling of PSA levels (PSADT) were more likely to experience cancer spread, recurrence, and death. These findings provide valuable pretreatment prognostic factors for prostate cancer.
Researchers found that light exposure triggers a massive surge of corticosterone in mice, playing a key role in physiological changes evoked by light. The study suggests light therapy may have beneficial effects on patients with seasonal affective disorder and other metabolic disorders.
Researchers have identified three newly recognized bacteria highly specific to bacterial vaginosis, a condition affecting up to 10% of pregnant women. The study aims to understand why lesbians and bisexual women are more likely to experience BV and develop strategies to prevent its recurrence.
A single-visit program for cervical cancer screening improved follow-up rates by 53% compared to traditional care, with high-grade lesions also showing increased adherence. The program reduced overall visit time while maintaining patient acceptability, offering a promising solution for underserved communities.
Researchers will focus on understanding human stem cells, transplanting them into patients for leukemia and lymphoma treatment, and using natural killer cells to fight cancer. The funding also aims to apply what has been learned about the use of natural killer cells in fighting diseases including leukemia and breast cancer.
Initial combination therapy with either prednisone or infliximab significantly reduces progression of radiographic joint damage and improves functional outcomes compared to DMARDs alone or step-up combination therapy. Patients treated with initial combination therapy also experience earlier relief from symptoms.
A study of 1901 women with early-stage breast cancer found that longer tamoxifen treatment periods resulted in improved overall survival, particularly in younger patients. Women aged 50-55 showed significant overall survival improvement after five years of treatment.
Computer simulations reveal that heat conduction is surprisingly high between liquid interfaces, challenging conventional wisdom on thermal conductivity. This finding has significant implications for fields like cancer treatment and computer chip manufacturing.
Researchers found a possible genetic link between cystic fibrosis gene mutations and young-onset pancreatic cancer. The study showed that individuals carrying the CFTR gene mutation are at increased risk for pancreatitis, which may also increase the risk of developing pancreatic cancer.
A recent study examined mortality and complications within 30 days following radical prostatectomy in 11,010 men who underwent the surgery between 1990 and 1999. The study found that age was associated with an increased risk of 30-day mortality, but the absolute risk of death was low even among men ages 70 to 79.
A study published in Cancer Cell reveals that combining therapies targeting EGFR and Akt can improve treatment outcomes in tumor cells with PTEN mutations. The research demonstrates that BAD acts as a key switch integrating antiapoptotic effects of multiple pathways, providing new insights into combination therapy strategies.
The American Association for Cancer Research will honor Senator Arlen Specter for his tireless support of biomedical research funding. His leadership and collaboration have led to significant advancements in cancer care, making Pennsylvania a hub for cutting-edge research institutions.
The European Infliximab for Psoriasis Efficacy and Safety Study (EXPRESS) found that 80% of patients achieved at least a 75% improvement in symptoms after ten weeks treatment with the drug. The study showed significant skin clearance and nail psoriasis response in moderate to severe psoriasis sufferers.
Researchers have discovered that gold nanoparticles can selectively target and kill cancer cells by absorbing light, offering a potential solution for early detection and treatment of various cancers. The technique is simple, inexpensive, and non-toxic to human cells.
Researchers at Thomas Jefferson University identified a genetic mutation in the Stratifin gene that causes abnormal skin development and cancer in mice. The study found that mice with the mutation developed severe skin defects, including cyclical hair loss and skin cancer late in life.
Researchers identified genetic signatures that predicted patient prognosis and response to treatment, outperforming existing clinical markers. The technique of DNA microarray analysis holds promise for developing new prediction methods, sparing patients from unnecessary treatments.
Researchers identify 64 genes used to separate breast cancer patients with good and poor prognoses. The technique of DNA microarray analysis could help predict patient response to adjuvant therapy, avoiding unnecessary treatments.
Studies examine prevalence of primary HIV infection, effectiveness of antidepressants in primary care, and the impact of patient-centered communication on healthcare costs. Research also explores aggressive antibiotic treatment for nursing home patients and cost-effectiveness of expanded testing for primary HIV infection.
Patients with fever of unknown origin have a higher risk of developing cancer, particularly haematological and sarcomas, than the general population. After several years of follow-up, diagnostic bias is believed to be a contributing factor to the association.
Researchers found that pomegranate extract killed more cells at higher doses, and mice treated with pomegranate extract showed slowing of cancer progression and reduced PSA levels. The study adds to growing evidence that pomegranates have powerful agents against cancer.
Men who survive testicular cancer are at higher risk of developing a second cancer for at least 35 years after diagnosis, mostly due to late side effects of treatment. Cancers such as bladder, colon, and stomach cancers account for most excess risks, with young patients facing even greater dangers.
A study found significant deficiencies in education on palliative surgical care among surgeons, with 84% not receiving any training during residency and 44% lacking continuing medical education. The lack of standardization in treatment recommendations may be due to diverse sources of training and experience.
The current treatment approaches for port-wine stains, facial hemangiomas, and vascular malformations are presented. Pulse-dye laser therapy is found to be an effective treatment for port-wine stains, while observation may suffice for stable lesions.
Researchers investigated tumour necrosis factor alpha, finding higher levels in severe asthmatics with chronic disease resistant to steroid treatment. A treatment using a TNF-alpha blocking drug improved symptoms and lung function in patients with severe asthma.
Chronic leukemia affects 9,700 Americans annually, with unusual microRNAs enabling damaged cells to survive. Researchers discovered that miR-15 and miR-16 play a crucial role in controlling Bcl-2 levels, leading to tumor growth.
A study found that nearly 60% of prostate cancer specimens received higher Gleason scores than original assignments, suggesting that pathologists are more likely to assign high scores to contemporary tumor samples. This 'Will Rogers phenomenon' may lead to a false sense of therapeutic accomplishment and skew mortality rates.
Researchers found that pomegranate fruit extracts inhibit the overproduction of MMP enzymes in human cartilage cells, slowing cartilage degradation in osteoarthritis. The findings suggest a potential therapeutic effect for consuming pomegranate fruit extract to protect cartilage.
Researchers at VCU are developing magnetic nanoparticles that can combine detection and treatment in a single process, promising new hope for breast cancer treatment. The nanoparticles use magnetodynamic therapy to kill tumor cells with minimal damage to healthy cells.
A team of researchers has discovered a molecular missing link that explains why fasting brings on acute attacks of the genetic disease hepatic porphyria. Fasting increases levels of PGC-1a, which regulates the activity of an enzyme in the heme production pathway, leading to toxic buildup of precursor molecules.
Researchers discovered a potential biomarker, PKCi, which predicts outcome in non-serous ovarian cancer when combined with Cyclin E. High levels of the protein correspond to reduced survival rates.
A 15-year longitudinal study found that individuals diagnosed with minor depression were more likely to develop major depression, particularly among young adults (18-29 years old) and women. The study also revealed that cancer and other chronic illnesses did not increase the risk of developing major depression.
Researchers at VCU's Massey Cancer Center have discovered a key enzyme involved in the spread of breast cancer cells. The study, published in the Journal of Biological Chemistry, suggests that sphingosine kinases are potential new targets for cancer therapy.
Contracting with non-state entities like NGOs has been shown to improve health services in developing countries through substantial, rapid improvements. Studies have found that contracting costs between $3 and $6 per head per year can increase immunisation coverage by up to 40 percentage points compared to government provision.
Researchers found improved patient outcomes in open nephron-sparing surgery (NSS) over time, attributed to increased surgeon experience and perioperative care. Open NSS showed benefits compared to laparoscopic NSS, particularly in complex tumor cases.
Researchers used diffusion MRI to measure water movement in treated fibroids, showing significant signal intensity and ADC values. This non-invasive technique may improve monitoring of ultrasound treatment success and be useful for other focused ultrasound treatments.
A study published in Cancer journal found that tumor size decreased significantly between 1975 and 1999, explaining 61% of the increased survival rate in localized breast cancer. Adjusting for tumor size diminished the magnitude of the survival increase within each stage category.
Dr. Gragoudas is being recognized for his groundbreaking work on protein beam irradiation and photodynamic therapy for intraocular melanoma and neovascular age-related macular degeneration. He has made significant contributions to the clinical practice of ophthalmology, particularly in the study of retinal vascular diseases.
Scientists at Ohio State University created a mouse model of lung cancer that loses the FHIT gene's protein early in development, leading to larger and more numerous tumors. The study suggests that even low levels of the protein might prevent lung cancer.
Researchers found that many cancer survivors make significant modifications in diet and physical activity after a diagnosis. Despite this, many continue to struggle with healthy behaviors, particularly males, less educated individuals, and those over 65.
The study reveals that hyperactive Stat3 shuts down a vital controller of stomach cell growth, leading to cancer formation. Lowering Stat3 hyperactivity suppresses stomach cancer formation without affecting other roles in the body.
A study analyzed data from 18 published studies on TP53 protein and mortality rates, finding selective reporting biases that may have fabricated strong associations. The authors caution that the findings highlight limitations of current research methods and call for more transparent reporting and better study design.
Resistant tumor cells can be sensitized to ONYX-015 replication by inducing a heat shock response, which could greatly augment the therapy's clinical utility. This study suggests that clinical strategies focusing on tumor-selective replication would favor the use of ONYX-015.
Researchers found that the p16 gene inactivates key enzymes JNK 1 and JNK 2, keeping them from activating proteins that promote cell growth. A small protein mimicking p16 has been designed to mimic its action, showing promise for anti-cancer activity.
Men with prostate cancer are 10% less likely to be working six months after diagnosis compared to those without the disease. However, approximately two-thirds of patients continue to work due to fear of losing health insurance coverage, often at reduced hours and with decreased productivity.